These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6751077)

  • 1. Progress toward a preferred method of monitoring the sterility of intravenous admixtures.
    Akers MJ
    Am J Hosp Pharm; 1982 Aug; 39(8):1297. PubMed ID: 6751077
    [No Abstract]   [Full Text] [Related]  

  • 2. Determining a time frame for sterility testing of intravenous admixtures.
    DeChant RL; Furtado D; Smith FM; Godwin HN; Domann DE
    Am J Hosp Pharm; 1982 Aug; 39(8):1305-8. PubMed ID: 6751079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of three methods for detecting low-level bacterial contamination in intravenous solutions.
    Miller CM; Furtado D; Smith FM; Godwin HN; Hogan LC; Letendre DE
    Am J Hosp Pharm; 1982 Aug; 39(8):1302-5. PubMed ID: 6812414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of three methods for detecting bacterial contamination in intravenous solutions.
    Hoffman KH; Smith FM; Godwin HN; Hogan LC; Furtado D
    Am J Hosp Pharm; 1982 Aug; 39(8):1299-302. PubMed ID: 6751078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial contamination of intravenous fluids opened in unsterile air.
    Arnold TR; Hepler CD
    Am J Hosp Pharm; 1971 Aug; 28(8):614-9. PubMed ID: 4937253
    [No Abstract]   [Full Text] [Related]  

  • 6. [Results of the first 6 months' experience in the monitoring of the sterility of injectable solutions].
    Pappalardo G
    Rev Med Suisse Romande; 1986 Feb; 106(2):163-71. PubMed ID: 3515496
    [No Abstract]   [Full Text] [Related]  

  • 7. Sterility-testing program for antibiotics and other intravenous admixtures.
    Choy FN; Lamy PP; Burkhart VD; Tenney JH
    Am J Hosp Pharm; 1982 Mar; 39(3):452-6. PubMed ID: 7041640
    [No Abstract]   [Full Text] [Related]  

  • 8. Microbiologic quality assurance for intravenous admixtures in a small hospital.
    Doss HL; James JD; Killough DM; Snodgrass GL
    Am J Hosp Pharm; 1982 May; 39(5):832-5. PubMed ID: 6805321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Problems of microbial contamination and sterility when administering drugs intravenously].
    Opulchenova G; Gencheva G
    Khirurgiia (Sofiia); 1983; 36(5):471-4. PubMed ID: 6366342
    [No Abstract]   [Full Text] [Related]  

  • 10. A sensitive method for the rapid detection of bacterial contaminants in intravenous fluids.
    Denyer SP; Lynn R
    J Parenter Sci Technol; 1987; 41(2):60-6. PubMed ID: 3598821
    [No Abstract]   [Full Text] [Related]  

  • 11. Method for testing aseptic technique of intravenous admixture personnel.
    Dirks I; Smith FM; Furtado D; White SJ; Godwin HN
    Am J Hosp Pharm; 1982 Mar; 39(3):457-9. PubMed ID: 7041641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of two sterility testing methods for intravenous admixtures.
    Condella F; Eichelberger K; Foote LC; Griffin RE
    Hosp Pharm; 1980 Jun; 15(6):305-10. PubMed ID: 10247270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring contamination levels of in-use intravenous solutions using "total sample" techniques.
    Hanson AL; Shelley RM
    Am J Hosp Pharm; 1974 Aug; 31(8):733-5. PubMed ID: 4853252
    [No Abstract]   [Full Text] [Related]  

  • 14. [Presence of mechanical impurities in solutions for parenteral administration].
    Besedina IV
    Farmatsiia; 1976; 25(5):80-2. PubMed ID: 793868
    [No Abstract]   [Full Text] [Related]  

  • 15. [Particular pollution of the solutions for perfusion and of the material for parenteral injection].
    Vranckx H; Lambert G; Roland M
    J Pharm Belg; 1970; 25(2):115-32. PubMed ID: 5515736
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of laminar air flow and clean-room dress on contamination rates of intravenous admixtures.
    Brier KL; Latiolais CJ; Schneider PJ; Moore TD; Buesching WJ; Wentworth BC
    Am J Hosp Pharm; 1981 Aug; 38(8):1144-7. PubMed ID: 7270557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Particulate-matter content of D5/NS for injection: manufacturer difference and conformance with USP limits.
    Smith JK; Baumann RR; Gunning WT; Annancy L; Alexander KS
    J Parenter Sci Technol; 1988; 42(6):180-6. PubMed ID: 3273493
    [No Abstract]   [Full Text] [Related]  

  • 18. A study of particulate matter in I.V. infusion fluids--phase 2.
    Davis NM; Turco S
    Am J Hosp Pharm; 1971 Aug; 28(8):620-3. PubMed ID: 5092591
    [No Abstract]   [Full Text] [Related]  

  • 19. Quality of intravenous infusion fluids manufactured in Kenya.
    Aluoch-Orwa JA; Ondari CO; Kibwage IO; Hoogmartens J
    East Afr Med J; 1995 Dec; 72(12):800-4. PubMed ID: 8689981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Method of analyzing and determining the sterility of a 2% solution of levomycetin in a 40% solution of hexamethylenetetramine for intravenous injections].
    Ivanova LD; Sivertseva VN
    Farmatsiia; 1977; 26(1):68-71. PubMed ID: 858408
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.